Diagn Microbiol Infect Dis
December 2024
The World Health Organization (WHO) has set a target of eliminating viral hepatitis B and C by 2030. Vaccination against hepatitis B (HepB) remains the most effective strategy for controlling and eliminating Hepatitis B Virus (HBV) infection. The development of HepB vaccines started with plasma-derived vaccines, which have since been largely replaced by safer and more effective recombinant vaccines, now considered the gold standard for preventing HBV infections.
View Article and Find Full Text PDFGizzard erosion and ulceration syndrome (GEUS) is caused by a fowl adenovirus serotype 1 (FAdV-1) and was first reported in laying hens in Japan in 1993. This syndrome has emerged as an epizootic in Morocco since 2014, causing significant economic losses for the poultry industry, but no involvement of a FAdV has been confirmed. Thus, the objective of this work was to assess GEUS cases that occurred in the country and to determine the role of FAdVs in their occurrence.
View Article and Find Full Text PDFRecent technological advances in data science hold great promise in medicine. Large-sized high-quality datasets are essential but often difficult to obtain due to privacy, cost, and practical challenges. Here, we discuss synthetic data's generation, evaluation, and regulation, highlighting its current applications and limits.
View Article and Find Full Text PDFDiagn Microbiol Infect Dis
December 2024
In alignment with Morocco's national strategy for eliminating viral hepatitis, we aimed to characterize and update the virological profile of chronic hepatitis B patients. Demographic, serological and molecular parameters of 804 HBsAg-positive patients were retrospectively analyzed. Overall, 58.
View Article and Find Full Text PDF